Translational medicine in Catalonia: the case of liver oncology

Authors

  • Josep M. Llovet Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona.

Abstract

Biomedical research has improved during the last decade in Catalonia, which is currently a well-recognized international biomedical scientific hub. The policy of head-hunting and attraction of talent fostered by the Catalan Government through the ICREA Professorship initiative has been successful. In 2006, I was appointed as ICREA Professor and started a research group in Translational research in liver oncology at IDIBAPS-Hospital Clínic in Barcelona. This appointment was possible due to a suitable environment in this institution, both regarding liver and translational medical research. This article summarizes some of the major advancements in translational medicine, liver research and translational hepatic oncology achieved during the last decade.

 

Author Biography

Josep M. Llovet, Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona.

- Barcelona-Clínic Liver Cancer Group (BCLC), Unitat d’Hepatologia, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona.
- Mount Sinai Liver Cancer Program, Division of Liver Diseases. Icahn School of Medicine at Mount Sinai, New York, USA.
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona.

Downloads

Issue

Vol. 13 No. 1 (2017)

Section

Research reviews

License

This work is subject, unless the contrary is indicated in the text, the photographs or in other illustrations, to an Attribution —Non-
Commercial— No Derivative Works 3.0 Creative Commons License, the full text of which can be consulted at http://creativecommons.org/licenses/by-nc-nd/3.0/. You are free to share, copy, distribute and transmit the work provided that the author is credited and reuse of the material is restricted to non-commercial purposes only and that no derivative works are created from the original material.